Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable?
Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat. The post Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? appeared first on Investor's Business Daily.
Pfizer tock edged lower Tuesday on a "pretty uneventful quarter" as revenue from its Covid products helped drive a fourth-quarter beat.
The post Pfizer's Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
